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One important function of GABAB receptors is the control of neuronal activity to
prevent overexcitation and thereby excitotoxic death, which is a hallmark of cerebral
ischemia. Consequently, sustained activation of GABAB receptors with the selective
agonist baclofen provides neuroprotection in in vitro and in vivo models of cerebral
ischemia. However, excitotoxic conditions severely downregulate the receptors, which
would compromise the neuroprotective effectiveness of baclofen. On the other hand,
recent work suggests that sustained activation of GABAB receptors stabilizes receptor
expression. Therefore, we addressed the question whether sustained activation of
GABAB receptors reduces downregulation of the receptor under excitotoxic conditions
and thereby preserves GABAB receptor-mediated inhibition. In cultured neurons
subjected to oxygen and glucose deprivation (OGD), to mimic cerebral ischemia, GABAB
receptors were severely downregulated. Treatment of the cultures with baclofen after
OGD restored GABAB receptor expression and reduced loss of neurons. Restoration
of GABAB receptors was due to enhanced fast recycling of the receptors, which
reduced OGD-induced sorting of the receptors to lysosomal degradation. Utilizing the
middle cerebral artery occlusion (MCAO) mouse model of cerebral ischemia, we verified
the severe downregulation of GABAB receptors in the affected cortex and a partial
restoration of the receptors after systemic injection of baclofen. Restored receptor
expression recovered GABAB receptor-mediated currents, normalized the enhanced
neuronal excitability observed after MCAO and limited progressive loss of neurons.
These results suggest that baclofen-induced restoration of GABAB receptors provides
the basis for the neuroprotective activity of baclofen after an ischemic insult. Since
GABAB receptors regulate multiple beneficial pathways, they are promising targets for a
neuroprotective strategy in acute cerebral ischemia.
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INTRODUCTION
The main cause for progressing neuronal death in cerebral
ischemia is excitotoxicity. Massive release of glutamate
excessively stimulates glutamate receptors, resulting in
neuronal overexcitation and apoptotic death (Lipton, 1999;
Szydlowska and Tymianski, 2010; Kostandy, 2012; Bano and
Ankarcrona, 2018; Choi, 2020). Under physiological conditions,
the excitability of neurons is precisely controlled by G protein
coupled GABAB receptors (Chalifoux and Carter, 2011a).
GABAB receptors are assembled from two subunits, GABAB1
and GABAB2, and are abundantly expressed at pre- and
postsynaptic areas of most neurons. Activation of GABAB
receptors by the neurotransmitter GABA provides long lasting
tonic inhibition mainly by suppression of voltage gated Ca2+
channel activity and activation of inwardly rectifying K+
channels. This inhibits neurotransmitter release via GABAB
receptors located at presynaptic sites and reduces neuronal
excitability via postsynaptic receptors (Gassmann and Bettler,
2012). One function of GABAB receptors is to act as an
“emergency brake” that prevents neurons from shifting into
overexcitation and apoptotic cell death (Chalifoux and Carter,
2011a). However, under the strong excitotoxic conditions caused
by cerebral ischemia, GABAB receptors are downregulated
(Kim et al., 2011; Zhu et al., 2015; Huang et al., 2017) and are
apparently no longer able to protect neurons from overexcitation.
Studies on cultured neurons revealed that downregulation of
GABAB receptors is primarily due to aberrant sorting of the
receptors to lysosomal degradation on the expense of recycling
them to the cell surface (Guetg et al., 2010; Maier et al., 2010;
Terunuma et al., 2010; Kantamneni et al., 2014).
Most G protein coupled receptors (GPCRs) undergo arrestin-
mediated internalization upon agonist stimulation, which
involves phosphorylation via G protein receptor kinases and
uncoupling the receptors from G proteins. This process stops
GPCR signaling and provides protection against excessive
receptor activity (Gurevich and Gurevich, 2019). In contrast,
activation of GABAB receptors appears to stabilize them at the
cell surface. Although activation of GABAB receptors accelerates
their internalization (Wilkins et al., 2008; Zhang et al., 2015),
this appears to be counterbalanced by their enhanced recycling
to the cell surface (Grampp et al., 2008; Zhang et al., 2015).
Agonist stimulated recycling of GABAB receptors involves the
recruitment of the small GTPase Rap1, which physically interacts
with GABAB receptors and promotes receptor recycling by an
unknown mechanism (Zhang et al., 2015).
Since sustained activation of GABAB receptors appears to
stabilize receptor numbers on the cell surface, it might well
be that this effect contributes to the neuroprotective activity of
the selective GABAB receptor agonist baclofen. Baclofen exhibit
neuroprotection in in vitro and in vivo models of cerebral
ischemia (Lal et al., 1995; Jackson-Friedman et al., 1997; Kulinskii
and Mikhel’son, 2000; Babcock et al., 2002; Dave et al., 2005;
Zhang et al., 2007; Xu et al., 2008; Cimarosti et al., 2009; Liu et al.,
2015). This suggests that either sustained activation of remaining
GABAB receptors after the ischemic insult is sufficient to promote
neuronal survival or, alternatively, that persistent activation of
the receptors stabilizes them at the cell surface and reduces their
downregulation, making the baclofen treatment more efficient.
In this study, we tested whether sustained activation
of GABAB receptors reduces their ischemia-induced
downregulation using cultured neurons subjected to oxygen
and glucose deprivation (OGD) and the middle cerebral artery
occlusion (MCAO) mouse model of cerebral ischemia. We
found that sustained activation of GABAB receptors restored
receptor expression by inhibiting the ischemia-induced aberrant
sorting of the receptors to the lysosomal degradation pathway.
This was due to enhanced fast recycling of the receptors. The
re-established GABAB receptor-mediated inhibition reduced
neuronal excitability and limited progressing loss of neurons.
MATERIALS AND METHODS
Antibodies and Drugs
The following primary antibodies were used in this study:
Rabbit anti NeuN (1:400 for microscopy, 1:1000 for Odyssey
Scanner, Millipore Cat# ABN78), mouse anti GABAB2 (1:400 for
microscopy, abcam Cat# ab181736), rabbit anti GABAB2 (1:2000
for Odyssey Scanner, abcam Cat# ab75838), mouse anti EEA1
(1:500, BD Biosciences Cat# 610456), mouse anti Rab11 (1:100,
Millipore Cat# 05-853), and goat anti Rab7 (1:50, Santa Cruz
Cat# sc-11303). Secondary antibodies: donkey anti rabbit Alexa
Fluor Plus 488 (1:2000, Thermo Fisher Scientific Cat# A32790),
donkey anti mouse Alexa Fluor Plus 555 (1:2000, Thermo Fisher
Scientific Cat# A32773), and goat anti rabbit Alexa Fluor Plus 800
(1:2000, Thermo Fisher Scientific Cat# A32735). All chemicals
used for electrophysiology solutions were purchased from Sigma-
Aldrich and baclofen was purchased from Tocris Bioscience.
Animals
Animal experiments were performed according to the national
guidelines of the Swiss Federal act on animal protection.
Experimental conditions were approved by the Cantonal
Veterinary Office Zurich, Zurich, Switzerland (license ZH152/16
and ZH011/19). MCAO experiments were performed using 9–
12 weeks old C57BL/6J male mice purchased from ENVIGO
(Netherlands). Mice were housed up to five per cage with a
standard 12/12-h light/dark cycle. Food and water were available
ad libitum. Primary neuron cultures were prepared from E18
embryos of time pregnant Wistar rats obtained from ENVIGO.
Primary Neuron Culture
Primary co-cultures of neurons and glia cells were prepared
from E18 Wistar rat embryos as described in Buerli et al.
(2007). Cells dissociated from minced cerebral cortex tissue were
plated at a density of 60,000 cells onto poly-D-lysine coated
15 mm diameter coverslips and incubated overnight in complete
Dulbecco’s modified Eagle Medium (DMEM; Thermo Fisher) at
37◦C and 5% CO2. Subsequently, medium was replaced by the
MEM/Nu-Serum based growing medium and kept at 37◦C and
5% CO2 for 12–16 days in vitro (DIV).
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Oxygen–Glucose Deprivation
Oxygen–glucose deprivation was carried out by replacing the
Nu-based culture medium by OGD medium (DMEM free of
glucose, glutamine, and phenol red) depleted from oxygen by
bubbling nitrogen for 15 min through the medium in a water
bath at 37◦C. Coverslips containing the cells were incubated in
OGD media in a hypoxic incubator (1% O2, 5% CO2, 37
◦C)
for 1 h. After the incubation, cells were transferred back to the
original conditionedmedium and incubated at 37◦C and 5%CO2
until further use.
Middle Cerebral Artery Occlusion
Transient MCAO was conducted using C57Bl/6J naïve male
mice as previously described (Vaas et al., 2017). Before the
surgery, mice were injected with buprenorphine (0.1 mg/kg,
s.c.) and with lidocaine (5 mg/kg, s.c.) at the site of incision.
The mice were anesthetized with 5% isoflurane and maintained
at 1.5–2% isoflurane in a mixture of O2 and air during the
surgery. The left common carotid artery was exposed through a
midline incision in the neck and unilateralMCAOwas conducted
by inserting a 7-0 silicone rubber-coated monofilament to
occlude the middle cerebral artery (Catalog No.: 701956PK5Re,
Doccol Corp., Sharon, MA, United States). The middle cerebral
artery was occluded for 60 min and then the filament was
withdrawn to allow reperfusion. Following the surgery, mice
were transferred to a 37◦C chamber for recovery before moved
back to the home cage. For sham operated mice, the surgery
was identical to the animals undergoing MCAO except that the
filament was inserted to occlude left MCA and immediately
withdrawn to allow instant reperfusion. Buprenorphine was
given every 6 h on the day of surgery and then supplied
via the drinking water (1 mg/kg). To encourage eating, the
mice received softened chow in a Petri-dish placed on the
floor of their cages. Baclofen (25 µg/kg, i.p.) was dissolved in
sterile PBS and injected immediately after starting reperfusion.
Sham operated mice were kept for 1 h in a recovery box at
37◦C and were injected at the same time point as MCAO
operated mice. Except for the experiment shown in Figure 3,
sham operated mice were sacrificed time matched with MCAO
operated mice. Successful MCAO surgery was assessed by testing
for impaired neurological/motor function using the Bederson
score (Schaar et al., 2010).
Electrophysiology and Acute Brain Slice
Preparation
For ex vivo electrophysiological recordings, sham or MCAO
operated mice were sacrificed 1 h after baclofen or saline
injection for slice preparation and recorded ex vivo within 3–
6 h. Isoflurane anesthetized mice were decapitated and their
brains quickly transferred into ice-cold solution containing
65 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM
NaHCO3, 7 mM MgCl2, 0.5 mM CaCl2, 25 mM glucose, and
105 mM sucrose saturated with 95% O2 and 5% CO2. Coronal
sections (300 µm) containing the cortical areas affected by
MCAO were sliced using a vibratome (HM 650, Microm). Slices
were transferred to a recovery chamber containing oxygenated
artificial cerebrospinal fluid (ACSF, 315 mOsm) saturated with
95% O2 and 5% CO2 and containing 125 mM NaCl, 2.5 mM
KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 1 mM MgCl2,
2 mM CaCl2, and 25 mM glucose at 34
◦C for 25 min and
then at room temperature. Following an additional 30 min
recovery period, the slices were transferred to a recording
chamber perfused with oxygenated ACSF at a flow rate of 1–
2 ml/min. All electrophysiology experiments were performed at
32–34◦C.
Neurons in the somatosensory cortex to be recorded
were visualized by infrared illumination using an Olympus
fluorescent microscope (BX51WI). Whole-cell patch-clamp
recordings were performed from excitatory neurons, which
were identified based on their morphology and firing patterns.
The intracellular solution used to measure GABAB receptor-
mediated GIRK currents and neuronal excitability consisted of
135 mM potassium gluconate, 2 mM NaCl, 4 mM KCl, 4 mM
EGTA, 10 mM HEPES pH 7.3, 4 mM Mg-ATP, and 0.3 mM
Na3GTP and was filled in borosilicate glass patch pipettes (3.5–
4.5 m).
Current-clamp experiments were performed using a series
of current steps (in 50 pA increments from −350 to 600 pA,
250 ms duration). Neurons were maintained at their original
resting membrane potential throughout the experiment. The
input resistance was determined usingOhm’s law after calculating
the slope of the current–voltage (I–V) curves obtained in current
clamp mode. The voltage responses were measured following
a series of 50 pA hyperpolarize current pulses, the resting
membrane potential (Vm) was determined immediately after
acquiring the whole cell patch mode and the firing threshold
(V th) was determined by injection of 5 pA depolarization current
steps until the first action potential was generated.
For agonist-induced currents, neurons were hold at −50 mV
and changes in holding currents in response to bath application
of 100 µMbaclofen were measured for 15 min. GABAB receptor-
mediated GIRK currents were confirmed by application of the
GABAB receptor antagonist CGP36742. For the analysis of GIRK
currents in cultured neurons, the cultures were subjected to
OGD and treated for 16 h with baclofen. After washing to
remove baclofen, baclofen-induced currents were measured for
a duration of 10 min.
Series resistance (Rs) was monitored throughout the
experiment and recordings were excluded from the analysis if the
Rs varied by 25%. Currents were filtered at 5 kHz and digitized at
20 kHz. All recordings were performed using a Multiclamp 700B
amplifier, acquired with Digidata 1550A, and analyzed offline
using Clampfit 10.5 (Molecular Devices).
Immunostaining and Image Analysis
Staining of Cultured Neurons
Total cell staining
Neurons were washed with PBS, fixated with 4%
paraformaldehyde (PFA) containing 4% sucrose for 20 min
and then permeabilized for 12 min with 0.2% Triton X-100
in PBS. Subsequently, neurons were incubated overnight at
4◦C with primary antibody diluted in PBS containing 10%
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normal goat serum (NGS) or normal donkey serum (NDS)
based on the antibody used. After extensive washing with PBS,
secondary antibodies were added for 1 h at room temperature.
Subsequently, the coverslips were washed with PBS and mounted
onto glass slides with DAKO fluorescence mounting medium for
analysis by confocal microscopy.
Cell surface staining
Cultured neurons were washed with incubation buffer (25 mM
HEPES pH 7.4, 119 mM NaCl, 5 mM KCl, 2 mM CaCl2,
2 mM MgCl2, 30 mM glucose) and incubated with anti-GABAB
receptor antibodies diluted in incubation buffer containing 10%
NDS for 2 h on ice. After washing with ice-cold incubation buffer,
the cultures were incubated with secondary antibodies for 1 h
on ice, washed again and fixated with 4% PFA containing 4%
sucrose for 15min at room temperature. The coverslips were then
mounted onto glass slides with DAKO fluorescence mounting
medium for analysis by confocal microscopy.
In situ proximity ligation assay
Proximity ligation assay was used tomonitor the colocalization of
GABAB receptors with endosomal marker proteins as previously
described (Maier et al., 2014; Zemoura et al., 2019). Cells were
washed with PBS, fixated with 4% PFA for 20 min at room
temperature followed by permeabilization with 0.2% Triton X-
100 in PBS for 10 min. The cells were then incubated overnight
at 4◦C with the appropriate pair of antibodies for GABAB
receptors and the endosomal marker protein diluted in PBS
containing 5% BSA. Subsequently, in situ PLA was performed
using the Duolink kit (Sigma Aldrich) exactly according to the
manufacturer’s instructions.
Cell survival assay
Neurons were subjected to OGD with a recovery period of
24 h. Thereafter, cells were washed with incubation buffer and
incubated in 7.5 µM propidium iodide solution (Sigma Aldrich)
for 25 min at 37◦C, 5% CO2. Subsequently, cultures were fixated,
permeabilized, and stained for neurons using NeuN antibodies.
Images were taken with a LSM 510 Meta confocal microscope
equipped with a Plan-Neofluar 40×/1.3 DIC oil-immersion
objective (Carl Zeiss) and the number of NeuN and propidium
iodide positive neurons was determined.
Confocal microscopy and quantitative image analysis
Images were recorded with a LSM 510 Meta confocal microscope
(Carl Zeiss) equipped with a Plan-Neofluar 40×/1.3 DIC and
Plan-Fluar 100×/1.45 DIC oil-immersion objective or with
a LSM 800 confocal microscope (Carl Zeiss) using a Plan-
Apochromat 40×/1.4 or 63×/1.4 DIC oil-immersion objective.
Images containing 4–5 optical sections with 0.4–1.0 µm spacing
were recorded at a resolution of 1024 × 1024 pixels and used
for the analysis of fluorescence intensities, counting of neurons
or the number of fluorescent spots in case of in situ PLA. Laser
intensities and detector gain were adjusted so that all signals
were below saturation. Images were analyzed using the ImageJ
software1.
1https://imagej.nih.gov/ij
For quantification of the cell surface staining, the optical
sections of each z-stack were merged into one image
and the outer and the inner perimeter of the cell surface
containing the fluorescence signals were exactly outlined.
Then the mean fluorescence intensity value obtained
from the inner border was subtracted from the one of
the outer border.
For quantification of in situ PLA signals, the cell soma was
marked carefully to allow particles quantification within the cell
using the ImageJ plug-inAnalyze Particles. Before counting signal
dots, a Gaussian blur filter was applied (sigma = 1), followed by
background subtraction (Rolling Ball radius = 30). The build-
in Moments algorithm was applied to determine the signal
threshold for all images. The number of dots representing the
PLA signal was then determined.
Staining of Brain Sections
Immunostaining
Following either sham or MCAO surgery, mice were
anaesthetized with pentobarbital (100 mg/kg, i.p.) and
transcardiacally perfused with ice-cold ACSF. Brains were
instantly extracted and embedded in NEG50 (Richard-Allan
Scientific, Fisher Scientific, Switzerland) and stored at −80◦C.
For immunostaining, 30 µm sections were cut using a cryostat
(Hyrax 60, Carl Zeiss) and mounted onto glass slides (SuperFrost
Plus, Thermo Scientific). The sections were fixated using 4% PFA
for 30 min at room temperature, followed by antigen retrieval
in a PickCell 2100-Retriever in 10 mM citrate buffer pH 6.0,
0.05% Tween 20 for 20 min. Sections were then permeabilized
(0.2% Triton X-100 in 10 mM Tris pH 7.4, 150 mM NaCl,
10% NGS) and incubated with primary antibody diluted in
TBST (10 mM Tris pH 7.4, 150 mM NaCl, 0.05% Tween-20)
containing 10% NGS overnight at 4◦C. After washing five
times for 5 min with TBST, the sections were incubated with
secondary antibodies (Alexa Fluor Plus 800) for 1 h at room
temperature. After washing with TBST, sections were air
dried in the dark and scanned with an Odyssey CLx infrared
scanner (Licor) at a resolution of 21 µm (Figures 4A, 6A) and
42 mm (Figure 3C).
Nissl staining
Paraformaldehyde fixated and permeabilized sections were
incubated for 15 min in 0.5% cresyl violet solution, washed
for 30 s in H2O and destained in ethanol for 20 s up to
2 min. The sections were then dehydrated by a series of
isopropanol, isopropanol/xylene and xylene incubations and
finally coversliped in Eukitt (Sigma Aldrich).
Statistical Analysis
Data represent means ± SD except for electrophysiological
results which are indicated as mean ± SEM for better display.
Statistical comparisons were made with either one-way or two-
way analysis of variance (ANOVA) followed by Tukey’s post hoc
tests. Statistical tests were performed using GraphPad Prism
8. Differences were considered statistically significant when
p < 0.05.
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FIGURE 1 | Baclofen treatment restored GABAB receptor surface expression and was neuroprotective after OGD stress in vitro. (A) Baclofen treatment after, but not
during, OGD increased GABAB receptor cell surface expression. Cultures were treated with baclofen (50 µM) during or after OGD. After 16 h after OGD, neurons
were then analyzed for the level of GABAB receptor surface expression using antibodies directed against GABAB2. The incubation time with baclofen was 1 h in the
“Bac during OGD” condition and 16 h in the “Bac after OGD” condition. Left, representative images (scale bar, 10 µm). Right: the bar graph depicts the
quantification of fluorescence intensities. The data represent the mean ± SD of 18–23 neurons per condition from two independent experiments. One-way ANOVA
followed by Tukey’s Multiple Comparison test (ns, p > 0.05; ***, p < 0.001; ****, p < 0.0001). (B) Treatment with baclofen after, but not during, OGD reduced
neuronal loss in vitro. Cultures were treated as in panel (A) and neuronal loss was determined using propidium iodide (red) and NeuN staining (green) 24 h after OGD.
Left, representative images (scale bar, 40 µm). Right: the bar graph depicts the quantification of fluorescence intensities. The data represent the mean ± SD of
40–41 neurons per condition from three independent experiments. One-way ANOVA followed by Tukey’s Multiple Comparison (ns, p > 0.05; **, p < 0.01; ****,
p < 0.0001). (C) Baclofen treatment normalized GABAB receptor mediated currents in OGD-stressed neurons. Cultured neurons were subjected to OGD and
treated or not for 16 h with baclofen. After washing to remove baclofen, baclofen-induced currents were measured for a duration of 10 min using whole cell voltage
clamp recordings. Right, representative voltage clamp traces. The data represent the mean ± SD of 6–9 neurons per condition from two independent neuron
preparations. One-way ANOVA with Tukey’s Multiple Comparison post hoc test (ns, p > 0.5; **, p < 0.01; ***, p < 0.001).
RESULTS
Baclofen Treatment After Excitotoxic
Stress in vitro Restored Cell Surface
Expression of GABAB Receptors
To investigate the impact of sustained baclofen activation of
GABAB receptors on cell surface expression of the receptors
under ischemic/excitotoxic conditions, we utilized OGD of
primary cortical neurons as an in vitro model. Consistent
with previous research (Guetg et al., 2010; Maier et al., 2010,
2014; Terunuma et al., 2010), exposing neurons to excitotoxic
conditions considerably reduced cell surface expression of
GABAB receptors (Figure 1A). To tested whether sustained
stimulation of GABAB receptors affects receptor surface
expression following OGD, we administered baclofen during
OGD or thereafter and determined cell surface expression of
the receptors after a recovery period of 16 h. Baclofen treatment
only during OGD did not affect cell surface GABAB receptor
expression, whereas application of baclofen after OGD restored
receptor expression close to control levels (Figure 1A). Under
these conditions, baclofen treatment only during OGD did not
affect loss of neurons tested 24 h after OGD, whereas treatment
after OGD significantly reduced loss of neurons (Figure 1B).
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The ineffectiveness of baclofen treatment when applied only
during OGD might be due to an inappropriate timing of the
application or to a too short duration of the application.
Finally, we tested whether baclofen treatment restoredGABAB
receptor function as measured by baclofen-induced K+ currents.
OGD strongly reduced baclofen evoked K+ currents in neurons
as compared to control neurons (Figure 1C), which is in
line with the considerable downregulation of the receptors
observed in Figure 1A. Treatment of OGD-stressed neurons
with baclofen immediately after OGD for 16 h restored GABAB
receptor-mediated currents to a level of unstressed control
neurons (Figure 1C).
To explore the pathway underlying the baclofen-induced
restoration of cell surface GABAB receptors after OGD, we
analyzed the co-localization of the receptors withmarker proteins
for early endosomes (EEA1) (Mu et al., 1995; Wilson et al.,
2000), fast recycling endosomes (Rab4) (van der Sluijs et al., 1992;
Daro et al., 1996), slow recycling endosomes (Rab11) (Ullrich
et al., 1996) and late endosomes (Rab7) (Feng et al., 1995)
using the in situ PLA. OGD did not affect the colocalization
of GABAB receptors with EEA1 (Figure 2A), Rab4 positive
fast recycling endosomes (Figure 2B) or Rab11 positive slow
recycling endosomes (Figure 2C). However, baclofen treatment
increased the colocalization of GABAB receptors with Rab4
under control condition and after OGD (Figures 2A,B). In
contrast, baclofen treatment strongly reduced the co-localization
of the receptors with Rab11 in control as well as in OGD
treated neurons (Figure 2C). This indicates a switch from
slow recycling Rab11 positive perinuclear endosomes to fast
recycling of the receptors from Rab4 positive endosomes. Finally,
OGD considerably increased the colocalization of GABAB
receptors with Rab7, indicating increased sorting to the lysosomal
degradation pathway (Figure 2D). Treatment with baclofen
significantly reduced the colocalization with Rab7 after OGD,
whereas under control conditions baclofen did not affect the
colocalization with Rab7 (Figure 2D). The expression levels of
endosomal marker proteins were not changed by the treatments
except for EEA1 (Figure 2A). Baclofen treatment increased EEA1
expression in control neurons but not in OGD stressed neurons.
Hence, the trend of enhanced colocalization of EEA1 and
GABAB receptors observed in baclofen-treated control neurons
(Figure 2A) might be caused by the upregulation of EEA1.
These findings suggest that sustained activation of GABAB
receptors after an ischemic insult reduces sorting of GABAB
receptors to lysosomal degradation by increasing fast recycling
on the expense of slow recycling.
Baclofen Treatment Partially Restored
Downregulated GABAB Receptor
Expression After Cerebral Ischemia
in vivo
To assess the effect of baclofen on the expression of GABAB
receptors in cerebral ischemia, we utilized the MCAO mouse
model of stroke. First, we determined the tempo-spatial
development of loss of neurons, to select suitable conditions for
the following experiments. Mice were subjected to 1 h of MCAO
and loss of neurons was determined in the neocortex at different
time points following reperfusion using Nissl and NeuN staining
(Figure 3A). Using Nissl staining, loss of neurons became visible
on a macroscopic level 3 h after re-establishing reperfusion in
the striatum and ventral cortex. It then spreads with time to
dorsal areas of the cortex (Figure 3B). Quantification of neuronal
loss using NeuN staining clearly showed progressing neuronal
death in the ventral and dorsal cortex, reaching severe levels in
the dorsal cortex considerably later than in the ventral cortex
(Figure 3C). Small but significant levels of neuronal loss were
present in the ventral and dorsal cortex 6 h after reperfusion
(Figure 3C). We used this time point to investigate the impact of
baclofen on the expression and function of GABAB receptors to
minimize the effect of neuronal loss in the following experiments.
At this timepoint, we observed a significant reduction in GABAB
receptor expression in the affected ipsilateral side, in both the
dorsal and ventral cortex, as compared to sham operated animals
(Figure 4). The magnitude of receptor downregulation exceeded
by far the low level of neuronal loss at this time point and,
therefore, could not be explained by a reduced number of
neurons. Receptor expression was partially recovered following
intraperitoneal injection of baclofen immediately after MCAO
(Figure 4). Thus, agonist stimulation of GABAB receptors after
cerebral ischemia partially restored GABAB receptor expression
in vivo.
Baclofen Treatment After MCAO
Restored GABAB Receptor-Mediated
Inhibition and Reduced Neuronal
Excitability
Next, we analyzed if baclofen treatment after MCAO also
restored GABAB receptor-mediated inhibition. GABAB-receptor
mediated currents were measured in the dorsal cortex 3–6 h
after starting reperfusion using ex vivo patch clamp recordings
in acute brain slices obtained from mice subjected to MCAO. In
line with the immunohistochemical data, we observed a strong
reduction of GABAB receptor-mediated currents in neurons
from MCAO-treated mice as compared to sham operated mice
(Figure 5A). Injection of baclofen immediately after starting
reperfusion restored GABAB receptor-mediated currents to a
level of sham operated mice (Figure 5A).
We then tested if the restored GABAB receptor-mediated
inhibition upon baclofen injection affects neuronal excitability.
Compared to sham operated mice, MCAO-treated mice
displayed a considerably higher neuronal excitability, as assessed
by the number of action potentials elicited by a series of
depolarizing current pulses. Injection of baclofen after MCAO,
strongly reduced the excitability to the level of sham operated
mice (Figure 5B).
To better understand the underlying mechanism by which
baclofen reduces neuronal excitability after cerebral ischemia,
we measured passive properties of the neurons. After MCAO,
the membrane conductance was decreased, as reflected by an
enhanced input resistance (Figure 5C) and a shift in the I–
V curve (Figure 5D), indicating increased excitability of the
neurons. Injection of baclofen normalized the input resistance
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FIGURE 2 | Sustained baclofen stimulation of GABAB receptors reduced sorting of the receptors to lysosomal degradation after OGD and increased fast recycling.
Cultured neurons were subjected (OGD) or not (Ctrl) to OGD for 1 h followed by incubation with baclofen (+Bac). Neurons were analyzed 16 h after OGD for the
colocalization of GABAB receptors with endosomal markers by in situ PLA (upper panels) and for expression of the marker proteins (lower panels) using antibodies
directed against GABAB2 and EEA1 (A), Rab4 (B), Rab11 (C), and Rab7 (D). (A) Baclofen treatment increased the colocalization of GABAB2 with the early
endosome marker EEA1 after OGD. Left, representative images depicting colocalization (upper panels) and EEA1 expression (lower panels) (scale bar, 10 µm). Right:
the bar graphs depicts the quantification of PLA signals and fluorescence intensities. The data represent the mean ± SD of 28–68 neurons per condition from thee
independent experiments for in situ PLA and 14–20 neurons per condition for EEA1 expression. Two-way ANOVA followed by Tukey’s post hoc test (ns, p > 0.05; **,
p < 0.005; ****, p < 0.0001). (B) Baclofen treatment increased the colocalization of GABAB2 with the fast recycling endosome marker Rab4. Left, representative
images (scale bar, 10 µm). Right: the bar graphs depicts the quantification of PLA signals and fluorescence intensities of Rab4 expression. The data represent the
mean ± SD of 39–46 neurons per condition from thee independent experiments for in situ PLA and 49–70 neurons per condition for Rab4 expression. Two-way
ANOVA followed by Tukey’s post hoc test (ns, p > 0.05; *, p < 0.05; **, p < 0.01; ****, p < 0.0001). (C) Baclofen treatment reduced colocalization of GABAB
(Continued)
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FIGURE 2 | Continued
receptors with the slow recycling endosome marker Rab11. Left, representative images (scale bar, 10 µm). Right: the bar graphs depicts the quantification of PLA
signals and fluorescence intensities of Rab11 expression. The data represent the mean ± SD of 13–26 neurons per condition from three independent experiments
for in situ PLA and 32–58 neurons per condition for Rab11 expression. Two-way ANOVA followed by Tukey’s post hoc test (ns, p > 0.05; *, p < 0.05; ***,
p < 0.001). (D) Baclofen treatment reduced the OGD-induced colocalization of GABAB receptors with the late endosome marker Rab7. Left, representative images
(scale bar, 10 µm). Right: the bar graphs depicts the quantification of PLA signals and fluorescence intensities of Rab7 expression. The data represent as
mean ± SD of 12–32 neurons per condition from two independent experiments for in situ PLA and 16–25 neurons per condition for Rab7 expression. Two-way
ANOVA followed by Tukey’s post hoc test (ns, p < 0.05; *, p < 0.05; **, p < 0.01; ****, p < 0.0001).
FIGURE 3 | Progressing neuronal loss in the cerebral cortex in the mouse
MCAO model of ischemic stroke. Mice were subjected to Sham or MCAO
surgery followed by 0, 3, 6, 9, 12, and 24 h reperfusion. Brains were then
fixated and analyzed for neuronal loss in the cerebral cortex using Nissl (B)
and NeuN (C) staining. (A) Scheme of the experimental design. (A′)
Schematic drawing of a coronal mouse brain section indicating the areas
analyzed in this study (dorsal and ventral cortex). (B) Representative images of
Nissl stained brain sections obtained from Sham and MCAO treated mice
reperfused for the indicated time intervals before fixation (scale bar, 1 mm).
(C) Representative images of NeuN stained brain sections (scale bar, 1 mm).
(C′) Quantification of fluorescence intensities of NeuN staining in the dorsal
cortex normalized to the fluorescence signals of the unaffected contralateral
cortex. (C′′) Quantification of fluorescence intensities of NeuN staining in the
ventral cortex normalized to the fluorescence signals of the unaffected
contralateral cortex. The data represent the mean ± SD of 12–25 brain
sections obtained from three mice and two independent staining experiments.
One-way ANOVA followed by Tukey’s Multiple Comparison post hoc test (ns,
p > 0.05; *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001).
and the shifted IV curve back to levels of sham operated mice
(Figures 5C,D). Furthermore, we did not observe a significant
difference in neuronal resting potential or firing threshold after
MCAO (Figures 5E,F). However, administration of baclofen
depolarized the firing threshold (Figure 5F), which is known to
contribute to the reduction on firing frequency observed in the
baclofen injected mice (Deng et al., 2009).
FIGURE 4 | Cerebral ischemia reduces the expression of GABAB receptor in
the neocortex. Mice were subjected to Sham or MCAO surgery and instantly
thereafter injected with baclofen (i.p., 25 mg/kg) or saline, followed by 6 h
reperfusion. (A) Representative coronal sections depicting the expression of
GABAB receptors (scale bar, 1 mm). (A
′) Quantification of the fluorescence
intensities in the ipsilateral dorsal cortex normalized to the corresponding
contralateral side. (A′′) Quantification of the fluorescence intensities in the
ipsilateral ventral cortex normalized to the corresponding contralateral side.
The data represent the mean ± SD of slices/mice obtained from:
sham = 43/6; MCAO = 39/5; MCAO + Baclofen = 60/8. The data points
represent the average fluorescence intensity derived from all slices analyzed
per mouse. One-way ANOVA followed by Tukey’s Multiple Comparison test
(**, p < 0.01; ***, p < 0.001; ****, p < 0.0001).
These results indicate that administration of baclofen
directly after re-establishing reperfusion in MCAO-treated mice
restored downregulated GABAB receptor-mediated inhibition
and reduced elevated excitability of neurons.
Baclofen Treatment Following Cerebral
Ischemia Reduced Neuronal Loss
To test the neuroprotective activity of the baclofen treatment, we
quantified NeuN staining in brain sections derived from MCAO
operated mice treated with baclofen or saline immediately after
starting reperfusion and sacrificed 6 h thereafter (Figure 6). In
line with the experiments shown in Figure 3, we observed a small
but significant level of neuronal loss at this early time point in the
dorsal cortex, which was prevented by treatment with baclofen
(Figure 6A′). In themore severely affected ventral cortex baclofen
likewise exhibited a neuroprotective effect (Figure 6A′′). These
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FIGURE 5 | Baclofen treatment rescued the ischemia-induced reduction of GABAB receptor-mediated currents and reduced neuronal hyperexcitability. (A) Baclofen
treatment normalized GABAB mediated currents in the ischemic brain. Coronal brain sections obtained from sham or MCAO treated mice were recorded ex vivo
within 3–6 h after baclofen or saline injection injection. Mice were sacrifized for slice perparation 1 h after baclofen or saline injection. Baclofen-induced currents were
measured for a duration of 15 min using whole cell voltage clamp recordings. Right, representative voltage clamp traces. One-way ANOVA with Tukey’s Multiple
Comparison post hoc test (ns, p > 0.5; *, p < 0.05; **, p < 0.01). (B) Baclofen injection reduced ischemia-induced neuronal hyperexcitability. The experimental
conditions were the same as in panel (A) except that recordings were obtained in the current clamp mode. Neurons of MCAO-treated mice show an increased
intrinsic excitability reflected by an increased number of action potentials elicited by a series of depolarizing current pulses (50 pA/250 ms from resting membrane
potential). Repeated measures ANOVA with mixed-effects analysis showed a significant interaction among AP counts and treatments [F (1.226,135.4) = 35.23,
p < 0.0001). Right, representative current clamp traces elected by 300 pA current pulse. (C–F) Baclofen reduced excitability by modulating intrinsic neuronal
properties. (C) While MCAO increased the input resistance, treatment with baclofen reduced the values to sham levels. This effect was calculated from the slope of
I–V curves (D). One-way ANOVA with Tukey’s Multiple Comparison post hoc test (ns, p > 0.05; **, p < 0.01; ***, p < 0.001). (E) The analysis revealed no change in
the resting membrane potential and no change in the neuronal firing threshold in MCAO mice. However, treatment with baclofen depolarized the action potential
firing threshold in MCAO mice. One-way ANOVA with Tukey’s Multiple Comparison post hoc test (ns, p > 0.05; *, p < 0.05). The data represent the mean ± SEM for
the number of cells/mice: sham = 19/6, MCAO = 16/5, R1 = 9/4, Rand = 11/5.
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FIGURE 6 | Baclofen treatment after MCAO is neuroprotective. Mice were
subjected to MCAO and injected with baclofen or saline followed by 6 h
reperfusion. (A) Representative images depicting the expression of NeuN
(scale bar, 1 mm). (A′) Quantification of the fluorescence intensities in the
indicated area in the ipsilateral dorsal cortex normalized to the corresponding
contralateral side. (A′′) Quantification of fluorescence intensities in the
ipsilateral ventral cortex normalized to the corresponding contralateral side.
The data represent the mean ± SD of slices/mice obtained from:
sham = 47/6; MCAO = 40/5; MCAO + Baclofen = 61/8). The data points
represent the average fluorescence intensity derived from all slices analyzed
per mouse. One-way ANOVA followed by Tukey’s Multiple Comparison test
(ns, p > 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001).
results indicate that baclofen treatment effectively promotes
survival of cortical neurons.
DISCUSSION
Here we show that sustained activation of GABAB receptors
after an ischemic insult restores downregulated GABAB receptor
expression and function, which limited excitotoxic neuronal
death. This study is based on previous work demonstrating that
GABAB receptors are severely downregulated under excitotoxic
conditions (Guetg et al., 2010; Maier et al., 2010, 2014; Terunuma
et al., 2010; Kim et al., 2011; Kantamneni et al., 2014; Zhu
et al., 2015; Huang et al., 2017) and indications from work
on GABAB receptors recombinantly expressed in HEK 293
cells that sustained activation of the receptors with baclofen
stabilized receptor expression on the cell surface (Zhang et al.,
2015). We hypothesized that treatment with baclofen after an
ischemic insult may reduce downregulation of the receptors and
re-establish GABAB receptor-mediated inhibition. This would
explain the well-established neuroprotective activity of baclofen
(Lal et al., 1995; Jackson-Friedman et al., 1997; Kulinskii and
Mikhel’son, 2000; Babcock et al., 2002; Dave et al., 2005; Zhang
et al., 2007; Xu et al., 2008; Cimarosti et al., 2009; Liu et al.,
2015) although the receptors are severely downregulated under
excitotoxic conditions.
Our in vitro experiments on cultured neurons subjected
to OGD, to mimic cerebral ischemia, verified the strong
downregulation of GABAB receptors reported previously under
excitotoxic conditions provoked by prolonged exposure to
NMDA or glutamate (Guetg et al., 2010; Maier et al., 2010;
Terunuma et al., 2010; Kantamneni et al., 2014). Treatment
of neurons with baclofen after OGD stress indeed recovered
GABAB receptor expression at the cell surface by the mechanism
proposed by Zhang et al. (2015) based on their finding on
receptors expressed in HEK 293 cells. Interestingly, baclofen
treatment after OGD restored downregulated receptor expression
close to normal levels. This finding indicates that under
ischemic conditions the supply of new receptors to the
cell surface, their internalization, recycling, and degradation
mechanisms are still in operation but with altered rates. Our
colocalization experiments with endosomal marker proteins
for the different intracellular trafficking pathways indicate
OGD-enhanced sorting of GABAB receptors to the lysosomal
degradation pathway, which is in line with previous reports
using NMDA and glutamate induced excitotoxicity (Maier
et al., 2010; Terunuma et al., 2010; Zemoura et al., 2019).
Our results show that baclofen treatment after OGD restores
cell surface receptor expression by increasing internalization
(as indicated by enhanced colocalization with EEA1 positive
endosomes) and fast recycling via Rab4 positive endosomes on
the expense of slow recycling via Rab11 positive endosomes. This
finding is in accordance with the observation that disruption of
GABAB receptor recycling increased lysosomal degradation of
the receptors (Grampp et al., 2008; Maier et al., 2010; Zhang
et al., 2015). Hence, our experimental data supports a mechanism
in which sustained activation of GABAB receptors by baclofen
induces fast recycling of the receptors to bypass sorting of the
receptors to the lysosomal degradation pathway.
Employing the MCAO mouse model of cerebral ischemia,
we confirmed progressing neuronal loss and diminished GABAB
receptor expression in the affected cerebral cortex, which were
partially restored after injection of baclofen directly after the
ischemic insult. Thus, these data recapitulate our in vitro findings
on cultured neurons subjected to OGD and verified OGD of
cultured neurons as valuable in vitro model for the analysis
of molecular mechanisms involved in cerebral ischemia. An
upregulation of GABAB receptor expression in animal models of
ischemia upon various treatments, including baclofen (Lu et al.,
2016), ferulic acid (Cheng et al., 2010), mild hypothermia (Kim
et al., 2011), and opposing needling/acupuncture (Xu et al., 2014;
Jiang et al., 2016), had been reported, suggesting that upregulated
GABAB receptor expression contributed to the neuroprotective
effect of the treatments.
As expected, restoration of GABAB receptors also recovered
the severely compromised GABAB receptor-mediated inhibition.
Although receptor expression was not fully recovered, baclofen
treatment restored GABAB receptor-mediated currents and
lowered enhanced neuronal excitability to levels of sham operated
mice. This was sufficient to inhibit ischemia-induced progressing
neuronal loss in the less affected dorsal cortex at the time point
of testing (6 h after starting reperfusion), whereas there was a
smaller neuroprotective effect of baclofen in the more severely
Frontiers in Molecular Neuroscience | www.frontiersin.org 10 September 2021 | Volume 14 | Article 726133
Hleihil et al. Baclofen Recovers GABAB Receptor Expression
affected ventral cortex. This result was expected since it is very
unlikely that any neuroprotective treatment, even when given
immediately after the ischemic insult, can prevent the almost
instantly occurring neuronal damage in the ischemic core.
One important advantage of targeting GABAB receptors
for neuroprotection lays in their regulation of multiple
beneficial pathways. The most obvious one is the inhibition of
glutamate release (Ouyang et al., 2007), reducing the detrimental
overstimulation of all members of the glutamate receptor family,
and the activation of postsynaptic GABAB receptors, which
inhibits neuronal excitability (Deng et al., 2009; Chalifoux
and Carter, 2011a,b). These combined effects reduce Ca2+
overload of the neurons and inhibit multiple mechanisms
of glutamate receptor and Ca2+ triggered apoptotic neuronal
death. In addition to inhibiting neuronal activity, sustained
GABAB receptor activity also promotes neuronal survival via the
PI3K/Akt-GSK3β pathway (Tu et al., 2010; Liu et al., 2015; Fu
et al., 2016), which is a major neuronal survival cascade (Rai
et al., 2019). Finally, baclofen treatment inhibits the upregulation
of the pro-apoptotic transcription factor CHOP, which induces
apoptotic cell death in response to ER-stress associated with
cerebral ischemia (Fu et al., 2016). These combined effects make
GABAB receptors a promising target for limiting progressing
neuronal death in acute cerebral ischemia.
Clinically, baclofen is effective for the treatment of post-
ischemic stroke symptoms, i.e., for the relief of severe spasticity
and associated pain (Taira et al., 1994; Meythaler et al., 2001;
Ivanhoe et al., 2006; Kofler et al., 2009; Creamer et al., 2018a,b)
and persistent hic-ups (Zhang et al., 2014). There is also
indication from animal studies for a potential benefit for the
treatment of anxiety (Lu et al., 2016) and sleep disturbances
(Hodor et al., 2014) associated with cerebral ischemia. However,
the neuroprotective activity of baclofen in acute stroke remains
to be established clinically. Considering the multiple beneficial
pathways targeted, sustained activation of GABAB receptors
might be a promising component for a therapy aimed at limiting
progressing excitotoxic neuronal death after an ischemic insult.
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